Fundraising Fox
Magnolia Medical Technologies
Seattle, US · Founded 2011 · Washington corporation · 82 employees on LinkedIn · 10 known investors
Find your way into Magnolia Medical Technologies
Sign up to see every warm intro you have to Magnolia Medical Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Magnolia Medical Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems. Its FDA 510(k)-cleared Steripath initial specimen diversion technology is used by clinical care teams to improve diagnostic accuracy for sepsis testing, primarily in the U.S.
Founders & leadership
Magnolia Medical Technologies was founded in 2011 by Gregory J Bullington and Richard Patton.
Board
Investors · 10
How we know: nsmedicaldevices.com · Not right? Tell us
How we know: Lauder Partners's portfolio page · Not right? Tell us
How we know: Marram Ventures's portfolio page · Not right? Tell us
How we know: Rhapsody Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Vivo Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · nsmedicaldevices.com · Not right? Tell us
How we know: a partner's Signal profile · nsmedicaldevices.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$91.6M disclosed across 6 rounds · 2015–2022
▶$43.4MraisedJan 2022 · 18 investors · Other Health CareRule 506(b)
- Paul EneverDirector
- Ronald LowyDirector
- Kathryn BealDirector
- Ovid AmadiDirector
- Paul MeisterDirector
- Gregory J BullingtonExecutive Officer, Director
- Marc-Andre MarcotteDirector
- Randy ScottExecutive Officer, Director
- Offering amount
- $46.4M
- Amount sold
- $43.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$19.6MraisedJan 2019 · 31 investors · Other Health CareRule 506(b)
- JOSH BALTZELLDirector
- PAUL MEISTERDirector
- RANDY SCOTTExecutive Officer, Director
- GREGORY J BULLINGTONExecutive Officer, Director
- RICHARD G PATTONExecutive Officer, Director
- PAUL ENEVERDirector
- Offering amount
- $20M
- Amount sold
- $19.6M
- First sale
- Dec 2018
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$21MraisedMar 2017 · 33 investors · Other Health CareRule 506(b)
- Paul M MeisterDirector
- Paul EneverDirector
- Josh BaltzellDirector
- Richard G PattonExecutive Officer, Director
- Gregory J BullingtonExecutive Officer, Director
- Garheng KongDirector
- Offering amount
- $21M
- Amount sold
- $21M
- First sale
- Jun 2016
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$70KraisedJun 2016 · 1 investors · Other TechnologyRule 506(b)
- Richard G PattonExecutive Officer, Director
- Paul M MeisterDirector
- Gregory J BullingtonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $70K
- First sale
- May 2016
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
▶$1.4MraisedMar 2016 · 6 investors · Other TechnologyRule 506(b)
- PAUL M MEISTERDirector
- GREGORY J BULLINGTONExecutive Officer, Director
- RICHARD G PATTONExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.4M
- First sale
- Feb 2016
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
▶$6.2MraisedJun 2015 · 9 investors · Other TechnologyRule 506(b)
- Paul MeisterDirector
- Richard G PattonDirector
- Gregory J BullingtonExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $6.2M
- First sale
- May 2015
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Magnolia Medical Technologies went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Magnolia Medical Technologies.
In the news
Frequently asked questions
- What does Magnolia Medical Technologies do?
- Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems. Its FDA 510(k)-cleared Steripath initial specimen diversion technology is used by clinical care teams to improve diagnostic accuracy for sepsis testing, primarily in the U.S.
- Who founded Magnolia Medical Technologies?
- Magnolia Medical Technologies was founded by Gregory J Bullington, Richard Patton in 2011.
- Who are Magnolia Medical Technologies's investors?
- Magnolia Medical Technologies's investors include Evidity Health Capital, Lauder Partners, Marram Ventures, Rhapsody Venture Partners, Vivo Capital, HealthQuest Capital, Janus Henderson Investors, RTW Investments L.P. and 2 more.
- How much funding has Magnolia Medical Technologies raised?
- Magnolia Medical Technologies has disclosed $91.6M raised across 6 rounds.
- Where is Magnolia Medical Technologies headquartered?
- Magnolia Medical Technologies is headquartered in Seattle, US.